Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Late recurrence of Wilms tumor after a 32-year disease-free interval: case report and literature review.
Journal: Frontiers in oncology
Published: February 03, 2026
Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.
Journal: Nature medicine
Published: November 01, 2025
Cervical vertebra plana secondary to Ewing sarcoma: A case report.
Journal: Radiology case reports
Published: September 20, 2025
Mithramycin alters EWS::FLI1 DNA binding and RNA polymerase II processivity to inhibit nascent transcription.
Journal: Nature communications
Published: February 11, 2025
Histone Deacetylase Inhibitors Target DNA Replication Regulators and Replication Stress in Ewing Sarcoma Cells.
Journal: Cancer research communications
Published: January 30, 2025
Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 16, 2023
Targeting the DNA damage response in pediatric malignancies.
Journal: Expert review of anticancer therapy
Published: September 13, 2022
Lurbinectedin Inhibits the EWS-WT1 Transcription Factor in Desmoplastic Small Round Cell Tumor.
Journal: Molecular cancer therapeutics
Published: December 13, 2021
Desmoplastic small round cell tumor is dependent on the EWS-WT1 transcription factor.
Journal: Oncogenesis
Published: October 25, 2019
Trabectedin Inhibits EWS-FLI1 and Evicts SWI/SNF from Chromatin in a Schedule-dependent Manner.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 26, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026